MDS PREP
Drug class causing free water clearance:
a) Diuretic
b) Saluretic
c) Uricosuric
d) Aquaretic
Pharmacology Answer: 4
Vasopressin antagonists like tolvaptan are aquaretics
Which of the following statement is not true about diuretics:
1) Acetazolamide is a carbonic acid anhydrase stimulant
2) Thiazides act on cortical diluting segment of loop of Henle
3) Frusemide is a high ceiling diuretic
4) Spironolactone is an aldosterone antagonist
Pharmacology Answer: 1
Acetazolamide is a carbonic acid anhydrase stimulant Acetazolamide, non-competitively (but reversibly) inhibits carbonic anhydrase in proximal tubular cells.
Tyrosine kinase inhibitors are useful in the management of ?
1) Acute myeloid leukemia
2) Small cell carcinoma of lung
3) Gastrointestinal stromal tumors
4) Neurofibromatosis
Pharmacology Answer: 3
Tyrosine kinase inhibitors are used in the treatment of:
Chronic myeloid leukemia
Acute lymphoblastic leukemia ( philadelphia chromosome positive cases )
Head and neck malignancies
Non small cell carcinoma lung
Gastrointestinal stromal tumours
Hepatocellular cancer
Renal cell carcinoma
Pancreatic cancer
Colorectal cancer
Which of the following is used in the treatment of meningococcal meningitis in patients allergic to penicillin?
1) Ciprofloxacin
2) Teicoplanin
3) Meropenem
4) Chloramphenicol
Pharmacology Answer: 4
Treatment of meningococcal meningitis:
Drug of choice – Penicillin G
In case of penicillin resistance, third generation cephalosporins should be used ( Ceftriaxone / CefotaximeIn case of penicillin / cephalosporin allergy, Chloramphenicol is used
Which of the following is used to decrease the toxicity of amphotericin B?
1) Dose reduction
2) Liposomal delivery systems
3) Supplementing glucose
4) Giving it along with flucytosine
Pharmacology Answer: 2
Liposomal delivery systems decrease the amount of free drug in the blood Infected cells interact with the liposomes, resulting in the release of amphotericin B at the site of action.
Which of the following statements is true regarding the phase III clinical trial of a drug?
1) It is intended to determine drug efficacy and toxicity on a large number of patients
2) It is performed only on primates
3) It is performed with only a few volunteer subjects
4) It is primarily intended to determine the LD50 of a drug
Pharmacology Answer: 1
Phase III studies are randomized controlled multicenter trials on large patient groups (300–3,000 or more depending upon the disease/medical condition studied) and are aimed at being the definitive assessment of how effective the drug is, in comparison with current 'gold standard' treatment.
Chelating agent contraindicated in iron and cadmium poisoning
1) Penicillamine
2) Des ferroxamine
3) EDTA
4) BAL
Pharmacology Answer: 4
Dimercaprol (British antilewisite; BAL)
1. Poisoning by As, Hg, Au, Bi, Ni, Sb: it is administered i.m., 5 mg/kg stat, followed by 2-3 mg/kg every 4 – 8 hours for 2 days, then once or twice a day for 10 days. It is partly oxidized and glucuronide conjugated, but mainly excreted as such in 4 – 6 hours. Earlier the treatment is instituted, the better it is. Because the dimercaprolmetal complex dissociates faster in acidic urine and the released metal can damage the kidney, urine is alkalinized during dimercaprol therapy.
2. As an adjuvant to Cal. Disod. Edentate in lead poisoning.
3. As an adjuvant to penicillamine in Cu poisoning and in Wilson’s disease – 300 mg/day i.m. for 10 days every second month.
It is contraindicated in iron and cadmium poisoning, because the dimercaprol-Fe and dimercaprol-Cd complex is itself toxic.
Ipratropium bromide is useful in bronchial asthma because of
1) Anticholinergic effect
2) Vasodilator properties
3) Antiallergic action
4) Stabilization of mast cells
Pharmacology Answer: 1
Ipratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic drug administered by inhalation for the treatment of obstructive lung diseases.
It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion.
It is a non-selective muscarinic antagonist, and does not diffuse into the blood, which prevents systemic side effects.
Ipratropium is a derivative of atropine[1] but is a quaternary amine and therefore does not cross the blood-brain barrier